Terms: = Pancreatic cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
3 results:
1. SUMO Modification of PAF1/PD2 Enables pml Interaction and Promotes Radiation Resistance in pancreatic Ductal Adenocarcinoma.
Rauth S; Karmakar S; Shah A; Seshacharyulu P; Nimmakayala RK; Ganguly K; Bhatia R; Muniyan S; Kumar S; Dutta S; Lin C; Datta K; Batra SK; Ponnusamy MP
Mol Cell Biol; 2021 Nov; 41(12):e0013521. PubMed ID: 34570619
[TBL] [Abstract] [Full Text] [Related]
2. pml hyposumoylation is responsible for the resistance of pancreatic cancer.
Swayden M; Alzeeb G; Masoud R; Berthois Y; Audebert S; Camoin L; Hannouche L; Vachon H; Gayet O; Bigonnet M; Roques J; Silvy F; Carrier A; Dusetti N; Iovanna JL; Soubeyran P
FASEB J; 2019 Nov; 33(11):12447-12463. PubMed ID: 31557059
[TBL] [Abstract] [Full Text] [Related]
3. Localisation and surgical treatment of insulinomas.
Gourgiotis S; Moustafellos P; Zavos A; Stratopoulos C; Vericouki C; Hadjiyannakis E
Int J Clin Pract; 2007 Apr; 61(4):558-61. PubMed ID: 17394431
[TBL] [Abstract] [Full Text] [Related]
